News

Filter

Current filters:

IluvienWomen's Health

1 to 9 of 96558 results

New angel investment initiative to boost funding for UK bioscience businesses

New angel investment initiative to boost funding for UK bioscience businesses

22-10-2014

Emerging bioscience companies in the UK will have access to new sources of funding as a result of an…

FinancialLondon Business AngelsPharmaceuticalUKUnited Kingdom

Ferring Pharma regains rights to DDAVP portfolio

22-10-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals says it has acquired DDAVP (desmopressin…

DiabetesGenito-urinaryLicensingPharmaceutical

aTyr Pharma appoints John McKew as vice president of research

22-10-2014

US rare disease company aTyr Pharma has named John McKew as vice president of research.

aTyrBiotechnologyBoardroomNational Institutes of HealthUSA

FDA advisory backs expanded use of Vertex’ CF drug

22-10-2014

There was good news for US biotech firm Vertex Pharmaceuticals yesterday, as a US Food and Drug Administration…

BiotechnologyKalydecoRare diseasesRegulationUSAVertex Pharmaceuticals

Roche to invest billions in new R&D facility and Basel updates

Roche to invest billions in new R&D facility and Basel updates

22-10-2014

Swiss pharma major Roche says it will invest 3 billion Swiss francs ($3.2 billion) in new research infrastructure…

FinancialGeography of EuropePharmaceuticalRocheSwitzerland

Ipsen to commercialize Lexicon carcinoid drug ex-North America/Japan

22-10-2014

French drugmaker Ipsen has entered into an accord with Lexicon Pharmaceuticals to commercialize the US…

EuropeIpsenLexicon PharmaceuticalsLicensingOncologyPharmaceuticaltelotristat etiprate

Amgen advised to consider ‘radical’ split by lead investor

Amgen advised to consider ‘radical’ split by lead investor

22-10-2014

One of Amgen’s largest shareholders has said the USA-based biotechnolgy comapny would be better off…

AmgenBiotechnologyFinancialThousand Oaks, CaliforniaUK

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

22-10-2014

US-Israeli Immune Pharmaceuticals has funded a study yielding clinical data to demonstrate the importance…

BiotechnologyGastro-intestinalsImmune PharmaceuticalsIsraelResearchUSA

1 to 9 of 96558 results

Back to top